ÈÕ±¾avÉ«ÇéƬ

Dr. DeSancho received her MD from the Autonomous University in Spain in 1983. Following a Residency in Family Practice at La Paz Hospital in Spain and a Residency in Internal Medicine at Metropolitan Hospital Center in New York, she completed fellowships in Hematology at Montefiore Medical Center from 1991-1992 and the Mount Sinai Medical Center from 1992-1993. Following this, she completed three additional fellowships at Mount Sinai in Transfusion Medicine, Medical Oncology, and Bone Marrow Transplantation. She obtained a faculty position at Columbia University as Assistant Professor of Clinical Medicine from 1997-2000, and in 2000 was appointed as Assistant Professor of Medicine and Assistant Attending Physician at Mount Sinai. Dr. DeSancho joined ÈÕ±¾avÉ«ÇéƬ Medical College in 2006 and is an Associate Professor of Clinical Medicine at the college and Associate Attending Physician at the New York-Presbyterian Hospital. She serves as Service Chief of the Division's Benign Hematology Service, has developed a successful clinical research program in Benign Hematology, and conducts clinical trails in Benign Hematology.

As a researcher, Dr. DeSancho's interest is in thrombosis and hemostasis, specifically thrombophilic disorders and women's health issues. She has participated in a number of important clinical studies. She has been Principal Investigator on many studies, including a Phase II multi center trail of a low molecular weight heparin for patients requiring bridging of anticoagulant therapy, a trial of cancer-associated thrombosis, and studies on thromboembolism in women's health. She is currently the principal investigator in a clinical trial for secondary prevention of venous thrombosis and in a clinical trial using plasma derived antithrombin in patients with hereditary antithrombin deficiency.